US$ 23.53
tirzepatide or semiglutide Semaglutide vs Tirzepatide, which is better for you? Tirzepatide vs Semaglutide: Which Medication
Description
For general guidance only, your provider tailors nutrition advice to your needs

Similar content being viewed by others Introduction Tirzepatide is a long-acting glucose-dependent insulinotropic polypeptide (GIP) receptor agonist (GIPRA) and glucagon-like peptide-1 (GLP-1) receptor agonist (GLP-1RA)

Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial

Clinical outcomes: Significant average weight loss, improved A1C, favorable effects on some cardiovascular risk markers in appropriate patients

[DOI] [PubMed] [Google Scholar] 17
